脑部放疗，上午比下午敏感许多！: y0 w" f% e. k' e# H' `( h
: c* T% {8 \3 p- \( Z/ O. }
0 j1 T1 e" `6 U5 fCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
2 O0 w5 B% `$ M. A: Y/ {Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
% f5 T# A- _5 P2 KRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.8 t4 X2 ~4 _7 K9 o3 {: l
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.. O1 A$ ?( U# I T! h$ a" a/ ^
& C3 e" [1 x$ e6 x, x1 o( ~
Abstract
% ~8 y% V' y1 iBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.: E- N$ z8 I& ^ M$ d- I% N1 G7 R
. Q1 c8 }& U$ G( {, J$ t3 d% tMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.. {- H9 |- A M
% p3 Q& {' L& n+ M6 l) }6 s* c- tRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)., o3 k$ j( d4 q! K
) P5 I" {& F7 e0 q$ }
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.$ o+ b0 X& O2 w$ f2 x+ x! n% u
# h9 v4 s6 f. R |
1 z6 g/ ~9 ^9 G7 W5 F7 }. W
显身卡
